1. Home
  2. BLTE vs STER Comparison

BLTE vs STER Comparison

Compare BLTE & STER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLTE
  • STER
  • Stock Information
  • Founded
  • BLTE 2018
  • STER 1975
  • Country
  • BLTE United States
  • STER United States
  • Employees
  • BLTE N/A
  • STER N/A
  • Industry
  • BLTE Biotechnology: Pharmaceutical Preparations
  • STER Computer Software: Prepackaged Software
  • Sector
  • BLTE Health Care
  • STER Technology
  • Exchange
  • BLTE Nasdaq
  • STER Nasdaq
  • Market Cap
  • BLTE 1.7B
  • STER 1.6B
  • IPO Year
  • BLTE 2022
  • STER 2021
  • Fundamental
  • Price
  • BLTE $57.60
  • STER $17.15
  • Analyst Decision
  • BLTE Strong Buy
  • STER Hold
  • Analyst Count
  • BLTE 4
  • STER 6
  • Target Price
  • BLTE $59.00
  • STER $16.20
  • AVG Volume (30 Days)
  • BLTE 40.3K
  • STER 333.2K
  • Earning Date
  • BLTE 11-12-2024
  • STER 11-06-2024
  • Dividend Yield
  • BLTE N/A
  • STER N/A
  • EPS Growth
  • BLTE N/A
  • STER N/A
  • EPS
  • BLTE N/A
  • STER N/A
  • Revenue
  • BLTE N/A
  • STER $736,509,000.00
  • Revenue This Year
  • BLTE N/A
  • STER $8.04
  • Revenue Next Year
  • BLTE N/A
  • STER $8.51
  • P/E Ratio
  • BLTE N/A
  • STER N/A
  • Revenue Growth
  • BLTE N/A
  • STER N/A
  • 52 Week Low
  • BLTE $31.01
  • STER $10.00
  • 52 Week High
  • BLTE $57.82
  • STER $17.42
  • Technical
  • Relative Strength Index (RSI)
  • BLTE 83.16
  • STER 64.22
  • Support Level
  • BLTE $55.63
  • STER $16.92
  • Resistance Level
  • BLTE $56.37
  • STER $17.35
  • Average True Range (ATR)
  • BLTE 1.65
  • STER 0.28
  • MACD
  • BLTE 0.53
  • STER 0.03
  • Stochastic Oscillator
  • BLTE 97.94
  • STER 74.88

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

About STER Sterling Check Corp.

Sterling Check Corp is a provider of technology-enabled background and identity verification services. It offers a hiring and risk management solution that begins with identity verification, followed by criminal background screening, credential verification, drug and health screening, processing of employee documentation required for onboarding, and ongoing risk monitoring. Its services are delivered through a purpose-built, proprietary, cloud-based technology platform that empowers organizations with real-time and data-driven insights to conduct and manage their employment screening programs.

Share on Social Networks: